These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10741551)

  • 1. The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds.
    Perrey DA; Scannell MP; Narla RK; Uckun FM
    Bioorg Med Chem Lett; 2000 Mar; 10(6):551-2. PubMed ID: 10741551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity.
    Perrey DA; Narla RK; Uckun FM
    Bioorg Med Chem Lett; 2000 Mar; 10(6):547-9. PubMed ID: 10741550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic phenyl arsonic acid compounds with potent antileukemic activity.
    Liu XP; Narla RK; Uckun FM
    Bioorg Med Chem Lett; 2003 Feb; 13(3):581-3. PubMed ID: 12565976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.
    Chen Q; Chao R; Chen H; Hou X; Yan H; Zhou S; Peng W; Xu A
    Int J Cancer; 2005 May; 114(5):675-82. PubMed ID: 15609303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Congeneric and QSAR of Homologous Antileukemic
    Castellano G; León A; Torrens F
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
    Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
    Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia.
    Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ
    Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel rhodanine derivatives induce growth inhibition followed by apoptosis.
    Moorthy BT; Ravi S; Srivastava M; Chiruvella KK; Hemlal H; Joy O; Raghavan SC
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6297-301. PubMed ID: 20832305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
    Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxicity of novel pyrido[1,2-e]purines on multidrug resistant human MCF7 cells.
    Pinguet F; Mavel S; Galtier C; Gueiffier A
    Pharmazie; 1999 Dec; 54(12):876-8. PubMed ID: 10631751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells.
    Opydo-Chanek M; Rak A; Cierniak A; Mazur L
    Toxicol In Vitro; 2017 Aug; 42():38-46. PubMed ID: 28366708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines.
    Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J
    J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of dithiole compounds.
    Yoshida E; Fukami T; Takamiya K; Okura A
    Anticancer Drug Des; 1988 Aug; 3(2):129-32. PubMed ID: 3408549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gram-scale synthesis of pinusolide and evaluation of its antileukemic potential.
    Shults EE; Velder J; Schmalz HG; Chernov SV; Rubalova TV; Gatilov YV; Henze G; Tolstikov GA; Prokop A
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4228-32. PubMed ID: 16781150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1.
    de Vasconcellos JF; Laranjeira AB; Leal PC; Bhasin MK; Zenatti PP; Nunes RJ; Yunes RA; Nowill AE; Libermann TA; Zerbini LF; Yunes JA
    PLoS One; 2015; 10(8):e0134783. PubMed ID: 26302043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
    Pieters R; Huismans DR; Loonen AH; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Lancet; 1991 Aug; 338(8764):399-403. PubMed ID: 1678081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.